You are here

Virtus Health present further evidence to support AI technology in embryo selection

11/10/2018

New data has been presented on the predictive value of the new artificial intelligence tool, Ivy. Ivy has, through analysis of time lapse images of IVF embryos, been shown to predict which embryos have the highest likelihood of leading to a viable pregnancy.

Aengus Tran, Chief Data Scientist at Harrison-AI and co-developer Dr Simon Cooke, Scientific Director at IVFAustralia, of Ivy, has presented the latest data on this system overnight at the American Society of Reproductive Medicine, in Denver. The significance of this work for the future of IVF has been recognised in the conference media release linked here.

Time-lapse videos of thousands of embryos during their development were used to ‘train’ the Ivy AI without the potential for interference from human bias or subjective assessment. The viability of Ivy, AI has been further validated since our preclinical data were originally announced in June 2018.

“Due to recent data collected from the Ivy, AI technology system, we have gained further confidence that Ivy will be the leading tool used in embryo selection in the future” says Dr Bill Watkins, Medical Director of TasIVF. “Using over 10,000 embryos from 1,603 patients aged between 22 and 50 (7.3 million images have been analysed) and Ivy has with 93% accuracy correctly identified whether an embryo will progress to a fetal heartbeat, validating our predictions and aim for patients to become pregnant sooner”

Virtus Health is rolling the Ivy, AI capability out through our network of laboratories in Australia and Europe to enable rapid introduction to patient care in the new year.